1. Terzis JK. Part 5: combating facial paralysis. Microreconstruction of nerve injuries. 1987. Philadelphia: WB Saunders.
2. Rubin LR. Re-animation of the Paralyzed Face. new approaches. 1977. St. Loius: C.V. Mosby.
3. Evans AK, Licameli G, Brietzke S, Whittemore K, Kenna M. Pediatric facial nerve paralysis: patients, management and outcomes. Int J Pediatr Otorhinolaryngol. 2005. 69:1521–1528. Epub 2005 Jun 27.
Article
4. Holland NJ, Weiner GM. Recent developments in Bell's palsy. BMJ. 2004. 329:553–557.
Article
5. Chan EH, Tan HM, Tan TY. Facial palsy from temporal bone lesions. Ann Acad Med Singapore. 2005. 34:322–329.
6. Marson AG, Salinas R. Bell's palsy. West J Med. 2000. 173:266–268.
Article
7. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of diVerent etiologies. Acta Otolaryngol Suppl. 2002. 549:4–30.
8. Prescott CA. Idiopathic facial nerve palsy (the eVect of treatment with steroids). J Laryngol Otol. 1988. 102:403–407.
9. Adour KK, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis. Diabetes. 1975. 24:449–451.
Article
10. Pitts DB, Adour KK, Hilsinger RL. Recurrent Bell's palsy: Analysis of 140 patients. Laryngoscope. 1988. 98:535–540.
11. Adour KK, Wingerd J. Idiopathic facial paralysis (Bell's palsy): factor affecting severity and outcome in 446 patients. Neurology. 1974. 24:1112–1116.
Article
12. Sullivan FM, Swan IR, Donnan PT. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007. 357:1598–1607.
Article
13. Selesnick SH, Patwardhan A. Acute facial paralysis: Evaluation and early management. Am J Otolaryngol. 1994. 15:387–408.
Article
14. Hato N, Matsumoto S, Kisaki H. Efficacy of early treatment of Bell's palsy with oral acyclovir and prednisolone. Otol Neurotol. 2003. 24:948–951.
Article
15. Adour KK, Ruboyiances JM, Von Doersten PG. Bell's palsy treatment with acyclovir and prednisolone compared with prednisolone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol. 1996. 105:371–378.
Article
16. Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007. 28:408–413.
17. Alberton DL, Zed PJ. Bell's palsy: a review of treatment using antiviral agents. Ann Pharmacother. 2006. 40:1838–1842.
Article
18. De Diego JI, Prim MP, De Sarria MJ, Madero R, Gavilan J. Idiopathic facial paralysis: A randomised, prospective and controlled study using single-dose prednisone versus aciclovir three times daily. Laryngoscope. 1998. 108:573–575.
Article
19. Antunes ML, Fukuda Y, Testa JRG. Clinical treatment of Bell's palsy: comparative study among valaciclovir plus deflazacort, deflazacort and placebo. Acta AWHO. 2000. 19:68–75.
20. Zhou P. Aciclovir in treating Bell's palsy. Chinese Journal of New Drugs and Clinical Remedies. 1999. 18:13–14.
21. Hunt JR. On herpetic inflammations of the geniculate ganglion. A new syndrome and its complications. J Nerv Ment Dis. 1907. 34:73–96.
Article
22. Hunt JR. Geniculate neuralgia (neuralgia of the nervus facialis). A further contribution to the sensory system of the seventh nerve and its neuralgic conditions. Arch Neurol Psychiat. 1937. 37:253–285.
23. Meier JL, Straus SE. Comparative biology of latent varicellazoster virus and herpes simplex virus infections. J Infect Dis. 1992. 166:13–23.
24. Byl FM, Adour KK. Auditory symptoms associated with herpes zoster or idiopathic facial paralysis. Laryngoscope. 1977. 87:372–379.
Article
25. Kim J, Jung JS, Moon IS, Lee HK, Lee WS. Statistical analysis of pure tone audiometry and caloric test in herpes zoster oticus. CEO. 2008. 1:15–19.
Article
26. Furuta Y, Ohtani F, Sawa H, Fukuda S, Inuyama Y. Quantitation of varicella-zoster virus DNA in patients with Ramsay Hunt syndrome and zoster sine herpete. J Clin Microbiol. 2001. 39:2856–2859.
Article
27. Furuta Y, Aizawa H, Ohtani F, Sawa H, Fukuda S. Varicella-zoster virus DNA level and facial paralysis in Ramsay Hunt syndrome. Ann Otol Rhinol Laryngol. 2004. 113:700–705.
Article
28. Aizawa H, Ohtani F, Furuta Y, Sawa H, Fukuda S. Variable patterns of varicella-zoster virus reactivation in Ramsay Hunt syndrome. J Med Virol. 2004. 74:355–360.
Article
29. Wackym PA, Popper P, Kerner MM, Grody WW. Varicella-zoster DNA in temporal bones of patients with Ramsay Hunt syndrome. Lancet. 1993. 342:1555.
Article
30. McKennan KX, Chole RA. Facial paralysis in temporal bone trauma. Am J Otol. 1992. 13:167–172.
31. Mchugh HZ. The surgical treatment of facial paralysis and traumatic conductive deafness in fracture of the temporal bone. Ann Otol Rhinol Laryngol. 1959. 68:855–889.
Article
32. Canon CR, Jahrsdoefer RA. Temporal bone fracture: Review of 10 cases. Arch Otolaryngol. 1989. 109:285–288.
33. Kelly KE, Tamz TA. Jacker RK, Brackmann DZ, editors. Temporal bone and skull base trauma. Neurotology. 1994. 1st ed. St. Louis: Mosby-Year Books Inc;1127–1147.
34. Khan AA, Maria M, Hinojosa R. Temporal bone fractures: A histopathologic study. Otolaryngol Head Neck Surg. 1985. 93:177–186.
Article
35. Travis LW, Stalnaker RL, Melvin JW. Impact trauma of human temporal bone. J Trauma. 1977. 17:761–766.
36. Lambert PR, Brackmann DZ. Facial paralysis in longitudinal temporal bone fracture: A review of 26 cases. Laryngoscope. 1984. 94:1022–1026.
37. May M, Shambaugh GE. Paparella MM, Shumrick DA, Gluckman JL, editors. Facial nerve paralysis. Otolaryngology. 1991. 3rd ed. Philadelphia: WB Saunders;1097–1136.
38. Fisch U. Facial paralysis in fractures of the petrous bone. Laryngoscope. 1974. 84:2141–2154.
Article
39. Adour KK, Boyajian JA, Kahn ZM, Schneider GS. Surgical and nonsurgical management of facial paralysis following closed head injury. Laryngoscope. 1977. 87:380–390.
Article
40. Fisch U. Lacrimation in facial nerve surgery. 1977. Birmingham: Aesculapius Publishing;147–153.
41. Yanagihara N. Transmastoid decompression of the facial nerve in temporal bone fracture. Otolaryngol Head Neck Surg. 1982. 90:616–621.
Article
42. Shambaugh GE, Clemis JD. Paparella , Shumrick , editors. Facial nerve paralysis. otolaryngology. 1973. vol.2. Philadelphia: WB Saunders;275.
43. Pulec JL. Symposium on ear surgery II. Facial nerve neuroma. Laryngoscope. 1972. 82:1160–1176.
44. Conley J, Janecka I. Neurolemmoma of the facial nerve. Plast Reconstr Surg. 1973. 52:55–60.
45. Neely JG. Neoplastic involvement of the facial nerve. Otolaryngol Clin North Am. 1974. 7:385–396.
Article
46. Alford BR, Gifford FR. A comprehensive study of the tumor of the glomus jugulare. Laryngoscope. 1962. 72:765–787.
47. Schuknect H. Neoplastic growth. pathology of the ear. 1974. Cambridge, MA and London, Eng: Harvard university press;415–418.
48. Arena S. Tumor surgery of the temporal bone. Laryngoscop. 1974. 84:645–670.
Article
49. Gantz BJ, Rubinstein JT, Gidley P, Woodworth GG. Surgical management of Bell's palsy. Laryngoscope. 1999. 109:1177–1188.
Article
50. Canter ARJ, Naedzelski JM, McLeasn JA. Evoked electromyography in Bell's palsy: a clinically useful test? J Otolaryngol. 1986. 15:344–347.
51. Coker NJ, Fordice JO, Moore S. Correlation of the nerve excitability test and electroneuronography in acute facial nerve paralysis. Am J Otol. 1992. 13:127–133.
52. Fisch U. Prognostic value of electrical tests in acute facial paralysis. Am J Otol. 1984. 5:494–498.
53. Canter ARJ, Naedzelski JM, McLeasn JA. Evoked electromyography in Bell's palsy: a clinically useful test? J Otolaryngol. 1986. 15:344–347.
54. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. 1981. 107:1–11.
Article
55. Sanuş GZ, Tanriöver N, Tanriverdi T, Uzan M, Akar Z. Late decompression in patients with acute facial nerve paralysis after temporal bone fracture. Turk Neurosurg. 2007. 17:7–12.
56. Quaranta A, Campobasso G, Piazza F, Quaranta N, Salonna I. Facial nerve paralysis in temporal bone fractures: outcomes after late decompression surgery. Acta Otolaryngol. 2001. 121:652–655.
Article
57. Kim J, Moon IS, Lee WS. Effect of delayed decompression after early steroid treatment on facial function of patients with facial paralysis. Acta Otolaryngol. 2009. 05. 13. 1–6.
Article
58. Eicher SA, Coker NJ, Alford BR, Igarashi M, Smith RJ. A comparative study of the fallopian canal at the meatal foramen and labyrinthine segment in young children and adults. Arch Otolaryngol Head and Neck Surg. 1990. 116:1030–1035.
Article
59. Nakashima S, Sando I, Takahashi H, Fujita S. Computer-aided 3-D reconstruction and measurement of the facial canal and facial nerve. I. Cross-sectional area and diameter: preliminary report. Laryngoscope. 1993. 103:1150–1156.
60. Ogawa A, Sando I. Spatial occupancy of vessels and facial nerve in the facial canal. Ann Otol Rhinol Laryngol. 1982. 91:14.
Article
61. Kim J, Chung SM, Moon IS, Lee HK, Lee WS. Correlation between enhanced MRI and surgical findings in herpes zoster oticus. Acta Otolaryngo. 2008. 3:1–6.
Article
62. Song MH, Kim J, Jeon JH, Cho CI, Yoo EH, Lee WS, Lee HK. Clinical significance of quantitative analysis of facial nerve enhancement on MRI in Bell's palsy. Acta Otolaryngol. 2008. 128:1259–1265.
Article
63. Sunderland S. Nerves and nerve injuries. 1978. 2nd ed. New York: Churchill Livingstone.
64. Felix H, Eby TL, Fisch U. New aspects of facial nerve pathology in temporal bone fractures. Acta Otolaryngol. 1991. 111:332–336.
Article
65. Chang CYJ, Cass SP. Management of facial nerve injury due to temporal bone trauma. Am J Otol. 1999. 20:96–114.
Article
66. Gormley W.B., Sekhar L.N., Wright D.C., Kamerer D., Schessel D.. Acoustic neuromas: results of current surgical management. Neurosurgery. 1997. 41:50–58.
Article
67. Samii M., Matthies C.. Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery. 1997. 40:11–23.
Article
68. Samii M., Gerganov V., Samii A.. Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients. J Neurosurg. 2006. 105:527–535.
Article
69. Wiggins RH 3rd, Harnsberger HR, Salzman KL, Shelton C, Kertesz TR, Glastonbury CM. The many faces of facial nerve schwannoma. AJNR Am J Neuroradiol. 2006. 27:1804. author reply 1805.
70. Lipkin AF, Coker NJ, Jenkins HA, Alford BR. Intracranial and intratemporal facial neuroma. Otolaryngol Head Neck Surg. 1987. 96:71–79.
Article
71. Lee JD, Kim SH, Song MH, Lee HK, Lee WS. Management of facial nerve schwannoma in patients with favorable facial function. Laryngoscope. 2007. 117:1063–1068.
Article
72. Fisch U, Rouleau N. Facial nerve reconstruction. J Otolaryngol. 1980. 9:487–492.
73. Luxford WM, Brackmann DE. Facial nerve substitution: a review of 66 cases. Am J Otol. 1985. 6:55–57.
74. Conley J. Hypoglossal crossover-122 cases. Tran Amer Acad Ophthalmol Otolaryngol. 1977. 84:763–768.
75. Atlas MD, Lowinger DSG. A new technique for hypoglossalfacial nerve repair. Laryngoscope. 1997. 107:984–991.
Article
76. Baker DC, Conley J. Regional muscle transposition for rehabilitation of paralyzed face. Clin Plast Surg. 1979. 6:317–331.
77. May M, Ducker C. Temporalis muscle for facial reanimation. A 13-year experience with 224 procedures. Arch Otolaryngol Head Neck Surg. 1993. 119:378–384.
Article
78. May M. Muscle transposition for facial reanimation-indications and results. Arch Otolarymgol. 1984. 110:184–189.